Patricia Alfonso

We want to take a moment to recognize the incredible work of scientists turning ideas into therapies that truly make a difference. 💖 💖 Helping you along the journey to create better medicines is not just our work—it's our passion. Wishing you a joyful holiday season! 🎉

🎉 Unlock the Power of Kinetic Selectivity – Get FREE Analysis at Enzymlogic! 🎉 Want to supercharge your compound profiling? Order a KINETICfinder® or COVALfinder® analysis by December 14, against 2+ kinase targets and get a FREE analysis on a kinase target of your choice!

📢 DYRK1 Made Degradable with #PROTACs! We are proud to have contributed to the characterization of Kd and residence time for DYR684. The latter is crucial for maximizing the efficacy of PROTACs. pubs.acs.org/doi/abs/10.1021…

🌟 If you’re at the Emergence of Irreversible Modulation in #DrugDiscovery meeting, make sure to swing by our booth! 🌟 We’re eager to show you how @enzymlogic can support your covalent drug discovery efforts. Whether you’re seeking insights or solutions, we’re here for you. 😀

𝗗𝗼𝗻’𝘁 𝗠𝗶𝘀𝘀 𝗧𝗵𝗶𝘀 𝗧𝗮𝗹𝗸! If you're at the @BritPharmSoc Emergence of Irreversible Modulation in #DrugDiscovery meeting, be sure to catch our presentation: "Decoding Irreversible Drug Kinetics: COVALfinder® Case Studies". 📅 October 16, at 14:45

📸 𝗦𝗽𝗲𝗰𝗶𝗮𝗹 𝗺𝗼𝗺𝗲𝗻𝘁 𝗮𝘁 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗼𝗻 𝗧𝗮𝗿𝗴𝗲𝘁 𝟮𝟬𝟮𝟰! It’s been amazing connecting with some brilliant minds at #DOT2024! We've been exchanging ideas and diving deep into exciting discussions about #drugdiscovery. So proud of the energy at our booth!

🚨 𝗛𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗼𝗻 𝗧𝗮𝗿𝗴𝗲𝘁 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗕𝗼𝘀𝘁𝗼𝗻?Don't miss our CSO presenting "Kinetic Profiling of Covalent Inhibitors using COVALfinder®" on 𝗠𝗼𝗻𝗱𝗮𝘆, 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟯𝟬𝘁𝗵 𝗮𝘁 𝟭𝟬:𝟯𝟬! #discoveryontarget #dot2024

🌟 𝗔 𝗕𝗜𝗚 𝗧𝗛𝗔𝗡𝗚 𝗬𝗢𝗨! 🌟 We’re thrilled by the overwhelming interest at our presentation "Kinetic Profiling of Covalent Inhibitors using COVALfinder®," at #DiscoveryOnTarget 2024!🙌 If you missed it, drop by (booth#302) and discover more about our innovative solutions!

Big News! Enzymlogic is excited to announce our Workshop in the 38th @AmerChemSociety Medicinal Chemistry Symposium! 📅 𝐉𝐮𝐧𝐞 𝟐𝟔 𝐚𝐭 𝟏𝟐:𝟏𝟓 𝐏𝐌. 📍 Session 6 - A Medicinal Chemist’s Toolbox 🔬 Kinetic Selectivity: a Missed Opportunity in Drug Design? #ACS #medchem

The energy at #ACS National Medicinal Chemistry Symposium is incredible! 🌟 We're thrilled by the interest in our services and the amazing opportunity to exchange innovative ideas with industry leaders. Visit our booth and discover how we can support your research! #chemspace

Seeking tools to accelerate #drugdiscovery and elevate clinical success rates? Explore the possibilities with KINETICfinder®! 🚀 enzymlogic.com/resources/app…

Discover how KINETICfinder® and COVALfinder® technologies work to facilitate: ✅ Medicinal chemistry iteration. ✅ Understand PK/PD disconnects. ✅ Build better models to define therapeutic windows. youtube.com/watch?v=o3Eh4qfA…

🤔Do you understand the safety profile of your compounds? Dive into our radical approach to drug discovery and challenge the conventional affinity-centric narrative– where affinity meets kinetics! Let's connect and talk kinetics! 😀enzymlogic.com/resources/aff…

⚡Proud to support the Tonge Laboratory with kinetic energy⚡ In this poster, we participated in the analysis of a series of Fenebrutinib-based BTK #PROTACs using our HTS kinetic platform KINETICfinder®: enzymlogic.com/resources/pro…

It is an honor to be recognized as a success story and we are deeply grateful for the support from #HorizonEurope and #CDTI. This backing is crucial in propelling our platform #KINETICfinder. Thank you for being part of our journey to success! 😊 research-and-innovation.ec.e…

🌐💊 Attention #drugdiscovery scientists, dive into our new application note!💡Navigate the realm of #bindingkinetics wisely - empower your drug discovery journey with informed assay choices! enzymlogic.com/resources/ben…

👩‍🔬Celebrating Our Unseen Heroes 👨‍🔬At the heart of breakthrough innovations, Enzymlogic’s team often operates behind the scenes, but their impact resonates far and wide.  Meet our incredible team that fuel the engine of progress in the world of #drugdiscovery.

🤔Are you a researcher in the #kinase domain?Uncover the secrets of #FLT3 activation state-dependent #kinetics and revolutionize your approach to designing novel drugs. #drugdiscovery enzymlogic.com/resources/app…

✨ 🚀 Eager to share one of our recent collaborations in covalent #kinase drug discovery, featured in this cutting-edge publication. Here, researchers have engineered a PET radiotracer based on a covalent BTK inhibitor that binds to the inactive form. pubs.acs.org/doi/full/10.102…